FR2453639A1 - Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl - Google Patents

Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl

Info

Publication number
FR2453639A1
FR2453639A1 FR7908937A FR7908937A FR2453639A1 FR 2453639 A1 FR2453639 A1 FR 2453639A1 FR 7908937 A FR7908937 A FR 7908937A FR 7908937 A FR7908937 A FR 7908937A FR 2453639 A1 FR2453639 A1 FR 2453639A1
Authority
FR
France
Prior art keywords
naftidrofuryl
drug composition
delayed release
release drug
based immediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7908937A
Other languages
English (en)
French (fr)
Other versions
FR2453639B1 (es
Inventor
Jacques Alexandre Chick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR7908937A priority Critical patent/FR2453639A1/fr
Priority to IL59765A priority patent/IL59765A/xx
Priority to IT67532/80A priority patent/IT1130110B/it
Priority to GB8011487A priority patent/GB2047096B/en
Priority to BE0/200164A priority patent/BE882706A/fr
Priority to ES490877A priority patent/ES490877A0/es
Publication of FR2453639A1 publication Critical patent/FR2453639A1/fr
Application granted granted Critical
Publication of FR2453639B1 publication Critical patent/FR2453639B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7908937A 1979-04-09 1979-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl Granted FR2453639A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR7908937A FR2453639A1 (fr) 1979-04-09 1979-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
IL59765A IL59765A (en) 1979-04-09 1980-04-03 Pharmaceutical preparation on the basis of naftidrofuryl which is release controlled
IT67532/80A IT1130110B (it) 1979-04-09 1980-04-04 Composizione medicamentosa a liberazione programmata immediata ritardo a base di naftidrofurile
GB8011487A GB2047096B (en) 1979-04-09 1980-04-08 Naftidrofuryl composition for immediate and delayed release
BE0/200164A BE882706A (fr) 1979-04-09 1980-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
ES490877A ES490877A0 (es) 1979-04-09 1980-04-09 Procedimiento para la fabricacion de portadores medicamento-sos programados

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7908937A FR2453639A1 (fr) 1979-04-09 1979-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl

Publications (2)

Publication Number Publication Date
FR2453639A1 true FR2453639A1 (fr) 1980-11-07
FR2453639B1 FR2453639B1 (es) 1982-03-19

Family

ID=9224133

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7908937A Granted FR2453639A1 (fr) 1979-04-09 1979-04-09 Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl

Country Status (6)

Country Link
BE (1) BE882706A (es)
ES (1) ES490877A0 (es)
FR (1) FR2453639A1 (es)
GB (1) GB2047096B (es)
IL (1) IL59765A (es)
IT (1) IT1130110B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
FR2539989B1 (fr) * 1983-01-28 1985-08-09 Sanofi Sa Medicament a liberation programmee associant l'acide acetylsalicylique a la dihydroergotamine
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
WO1995003052A1 (en) * 1993-07-22 1995-02-02 Warner-Lambert Company Controlled release tacrine drug delivery systems and methods for preparing same
DE4333190C2 (de) * 1993-09-29 1996-05-30 Korsatko Werner Univ Prof Dr E Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
ES2459322T3 (es) 2008-09-05 2014-05-09 Supernus Pharmaceuticals, Inc. Método de tratamiento de trastorno de déficit de atención con hiperactividad (TDAH)
US9358204B2 (en) * 2012-02-08 2016-06-07 Supernus Pharmaceuticals, Inc. Formulations of viloxazine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2350836A1 (fr) * 1976-05-13 1977-12-09 Shionogi & Co Preparation de cefalexine a longue duree d'action pour le traitement efficace d'infections bacteriennes sensibles a la cefalexine
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
DE2749745A1 (de) * 1977-09-15 1979-03-29 Heyden Chem Fab Nitrofurantoin-retard-praeparat zur oralen verabfolgung und verfahren zu seiner herstellung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2350836A1 (fr) * 1976-05-13 1977-12-09 Shionogi & Co Preparation de cefalexine a longue duree d'action pour le traitement efficace d'infections bacteriennes sensibles a la cefalexine
FR2377196A1 (fr) * 1977-01-13 1978-08-11 Lipha Composition medicamenteuse a usage oral
DE2749745A1 (de) * 1977-09-15 1979-03-29 Heyden Chem Fab Nitrofurantoin-retard-praeparat zur oralen verabfolgung und verfahren zu seiner herstellung
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication

Also Published As

Publication number Publication date
IT8067532A0 (it) 1980-04-04
BE882706A (fr) 1980-07-31
ES8100881A1 (es) 1980-12-01
IL59765A (en) 1983-12-30
FR2453639B1 (es) 1982-03-19
ES490877A0 (es) 1980-12-01
GB2047096B (en) 1983-08-24
IL59765A0 (en) 1980-06-30
GB2047096A (en) 1980-11-26
IT1130110B (it) 1986-06-11

Similar Documents

Publication Publication Date Title
FR2643556B1 (fr) Composition pharmaceutique a liberation prolongee d'acide valproique
TNSN87021A1 (fr) Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
ATE113585T1 (de) Aminsäure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
PT81946A (fr) Procede de preparation de nouveaux derives de l'acide alpha-<oxo-2-hexahydro-2,4,5,6,7,7a-thieno(3,2-c)pyridyl-5>phenyl acetique et de compositions pharmaceutiques les contenant
DK0413016T3 (da) Hidtil ukendte kompositioner indeholdende hyaluronnsyreassociater og fremgangsmåde til fremstilling heraf
FR2555584B1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
ATE25246T1 (de) Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
BE879487A (fr) Comprimes pharmaceutique pour une application par voie orale et son procede de preparation
IL88615A (en) 1,7-annelated indolecarboxylic acid esters and carboxamides,their preparation and pharmaceutical compositions containing them
FR2453639A1 (fr) Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
SE8901041D0 (sv) Antitrombotiska farmaceutiska preparat samt foerfarande foer deras framstaellning
FR2381521A1 (fr) Base pour des preparations medicamenteuses a usage externe, preparation medicamenteuses preparees a l'aide de celle-ci et procede pour leur preparation
FR2499408B1 (fr) Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique
BG102556A (en) Orally applied pharmaceutical composition with modified release containing 5-asa, and a method for the treatment of intestinal diseases
FR2617047B1 (fr) Composition de gelatine resistant au tannage, capsules a base de cette composition et leur application pharmaceutique, notamment au fenofibrate
ATE31300T1 (de) Imidazol-2-yl-mercaptoalkansaeuren, verfahren zu deren herstellung und pharmazeutische formulierungen welche diese enthalten.
HUP9902081A2 (hu) Gyulladásgátlóként használható, kéntartalmú di(terc-butil)-fenol-vegyületek
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
FR2707638B1 (fr) Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique.
BE893492A (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques prepares avec ces esters
FR2529081B1 (fr) Composition therapeutique a base d'acide 5-hydroxydecanoique ou d'un de ses derives pour le traitement des maladies cardiovasculaires
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.

Legal Events

Date Code Title Description
TP Transmission of property